Insulin analogues

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023 · see citing works

Untitled work

Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479 · see citing works

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818 · see citing works

Intermittent High Glucose Enhances Apoptosis Related to Oxidative Stress in Human Umbilical Vein Endothelial Cells

Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 771 · see citing works

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739 · see citing works

Standards of Medical Care in Diabetes

(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 684 · see citing works

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Yki‐Järvinen, H., Dressler, A., Ziemen, M., & HOE 901/300s Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1130 · Cited by 578 · see citing works

Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review

DeWitt, D. E., & Hirsch, I. B. (2003) · JAMA · doi:10.1001/jama.289.17.2254 · Cited by 502 · see citing works

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483 · see citing works

Basal Insulin Therapy in Type 2 Diabetes

Rosenstock, J., Schwartz, S. L., Clark, C. M., Park, G. D., Donley, D. W., & Edwards, M. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.631 · Cited by 477 · see citing works

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

Heinemann, L., Linkeschova, R., Rave, K., Hompesch, B., Sedlak, M., & Heise, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.644 · Cited by 474 · see citing works

[Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

Howey, D. C., Bowsher, R. R., Brunelle, R. L., & Woodworth, J. R. (1994) · Diabetes · doi:10.2337/diab.43.3.396 · Cited by 471 · see citing works

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes

Ratner, R. E., Hirsch, I. B., Neifing, J. L., Garg, S. K., Mecca, T. E., & Wilson, C. A. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.639 · Cited by 455 · see citing works

Type 1 diabetes: recent developments

Devendra, D., Liu, E., & Eisenbarth, G. S. (2004) · BMJ · doi:10.1136/bmj.328.7442.750 · Cited by 352 · see citing works

Insulin analogues and their potential in the management of diabetes mellitus

Bolli, G. B., DiMarchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051286 · Cited by 349 · see citing works

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

Kurtzhals, P., Havelund, S., Jonassen, I., Kiehr, B., Larsen, U. D., Ribel, U., & Markussen, J. (1995) · Biochemical Journal · doi:10.1042/bj3120725 · Cited by 334 · see citing works

Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 Diabetes

Fritsche, A., Schweitzer, M. A., H�ring, H.-U., & and the 4001 Study Group* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00006 · Cited by 331 · see citing works

Insulin: Discovery and Controversy

Rosenfeld, L. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.12.2270 · Cited by 329 · see citing works

Management of Diabetes Mellitus Complicating Pregnancy

Gabbe, S. G., & Graves, C. R. (2003) · Obstetrics and Gynecology · doi:10.1016/j.obstetgynecol.2003.07.001 · Cited by 325 · see citing works

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

Yki-Järvinen, H., Kauppila, M., Kujansuu, E., Lahti, J., Marjanen, T., Niskanen, L., Rajala, S., Ryysy, L., Salo, S., Seppälä, P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272005 · Cited by 324 · see citing works

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

Skyler, J. S., Cefalu, W. T., KOURIDES, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S., & Gelfand, R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03638-2 · Cited by 301 · see citing works

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

Vague, P., Selam, J.-L., Skeie, S., De Leeuw, I., Elte, J. W. F., Haahr, H., Kristensen, A., & Draeger, E. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.590 · Cited by 294 · see citing works

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

Mudaliar, S. R., Lindberg, F. A., Joyce, M., Beerdsen, P., Strange, P., Lin, A., & Henry, R. R. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1501 · Cited by 276 · see citing works

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

Bastyr, E. J., Stuart, C., Brodows, R. G., Schwartz, S. L., Graf, C. J., Zagar, A. J., & Robertson, K. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1236 · Cited by 274 · see citing works

Insulin Lispro in CSII: Results of a Double-Blind Crossover Study

Zinman, B., Tildesley, H. D., Chiasson, J., Tsui, E. Y. L., & Strack, T. R. (1997) · Diabetes · doi:10.2337/diab.46.3.440 · Cited by 255 · see citing works

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

Raskin, P., Klaff, L., Bergenstal, R., Hallé, J. P., Donley, D., & Mecca, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1666 · Cited by 250 · see citing works

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

Home, P., Olinder, A. L., Hylleberg, B., & Round, P. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1904 · Cited by 233 · see citing works

Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes

Brunelle, R. L., Llewelyn, J., Anderson, J. H., Gale, E. A. M., & Koivisto, V. A. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1726 · Cited by 216 · see citing works

Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

Owens, D. R., Coates, P. A., Luzio, S. D., Tinbergen, J. P., & Kurzhals, R. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.813 · Cited by 200 · see citing works

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

Renner, R., Pfützner, A., TRAUTMANN, M. E., Harzer, O., Sauter, K., & Landgraf, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.784 · Cited by 168 · see citing works

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

Howey, D. C., Bowsher, R. R., Brunelle, R. L., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.3.396 · Cited by 128 · see citing works

A Randomized Clinical Trial Comparing Breakfast, Dinner, or Bedtime Administration of Insulin Glargine in Patients With Type 1 Diabetes

Hamann, A., Matthaei, S., Rosak, C., Silvestre, L., & for the HOE901/4007 Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1738 · Cited by 124 · see citing works

Transfer of Insulin Lispro Across the Human Placenta

Boskovic, R., Feig, D. S., Derewlany, L. O., Knie, B., Portnoi, G., & Koren, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1390 · Cited by 123 · see citing works

Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine hagedorn insulin

Chase, H. P., Dixon, B., Pearson, J., Fiallo-Scharer, R. V., Walravens, P., KLINGENSMITH, G. J., Rewers, M., & Garg, S. K. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00415-3 · Cited by 122 · see citing works

Comparative Trial Between Insulin Glargine and NPH Insulin in Children and Adolescents with Type I Diabetes Mellitus

Schober, Ε., Schoenle, E. J., Dyk, J. V., Wernicke‐Panten, K., & Pediatric Study Group of Insulin Gl (2002) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2002.15.4.369 · Cited by 121 · see citing works

Insulin lispro and regular insulin in pregnancy

Bhattacharyya, A. (2001) · QJM · doi:10.1093/qjmed/94.5.255 · Cited by 114 · see citing works

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin

Kilo, C., Mezitis, N. H. E., Jain, R., Mersey, J. H., McGill, J. B., & Raskin, P. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00076-x · Cited by 113 · see citing works

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy

Gale, E. A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00258.x · Cited by 112 · see citing works

Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue

Tuominen, J. A., Karonen, S.-L., Melamies, L., Bolli, G. B., & Koivisto, V. A. (1995) · Diabetologia · doi:10.1007/bf02369359 · Cited by 111 · see citing works

Insulin lispro in CSII: results of a double-blind crossover study

Zinman, B., Tildesley, H., Chiasson, J., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.3.440 · Cited by 104 · see citing works

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group

Anderson, J. H., Brunelle, R. L., Koivisto, V. A., Pfutzner, A., TRAUTMANN, M. E., Vignati, L., & DiMarchi, R. D. (1997) · Diabetes · doi:10.2337/diabetes.46.2.265 · Cited by 99 · see citing works

Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.

Kitzmiller, J. L., Main, E. K., Ward, B., Theiss, T. S., & Peterson, D. L. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.874 · Cited by 95 · see citing works

Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta‐analysis

Colquitt, J. L., Royle, P., & Waugh, N. R. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01018.x · Cited by 95 · see citing works

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

Pfützner, A. H., Küstner, E., Forst, T. M., Schleppinghoff, B. S., TRAUTMANN, M. E., Haslbeck, M., Schatz, H., & Beyer, J. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211418 · Cited by 92 · see citing works

Immunologic Effects of Insulin Lispro [Lys (B28), Pro (B29) Human Insulin] in IDDM and NIDDM Patients Previously Treated With Insulin

Fineberg, N. S., Fineberg, S. E., Anderson, J. H., Birkett, M. A., Gibson, R. G., & Hufferd, S. (1996) · Diabetes · doi:10.2337/diab.45.12.1750 · Cited by 85 · see citing works

Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro

Loukovaara, S., Immonen, I., Teramo, K. A., & Kaaja, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1193 · Cited by 80 · see citing works

Efficacy of Conversion From Bedtime NPH Insulin Injection to Once- or Twice-Daily Injections of Insulin Glargine in Type 1 Diabetic Patients Using Basal/Bolus Therapy

Albright, E. S., Desmond, R., & Bell, D. S. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.632 · Cited by 75 · see citing works

Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial

Clement, S. C., Dandona, P., Still, J., & Kosutic, G. (2003) · Metabolism · doi:10.1016/j.metabol.2003.07.021 · Cited by 75 · see citing works

Effect of Long-Term Exposure to Insulin Lispro on the Induction of Antibody Response in Patients With Type 1 or Type 2 Diabetes

Fineberg, S. E., Huang, J., Brunelle, R. L., Gulliya, K. S., & Anderson, J. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.89 · Cited by 74 · see citing works

Meal Composition is a Determinant of Lispro-Induced Hypoglycemia in IDDM

Burge, M. R., Castillo, K. R., & Schade, D. S. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.152 · Cited by 72 · see citing works

Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

Koivisto, V. A., Tuominen, J. A., & Ebeling, P. R. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.459 · Cited by 71 · see citing works

A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump

Raskin, P., Holcombe, J. H., Tamborlane, W. V., Malone, J. I., Strowig, S., Ahern, J. A., & Lavent, F. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00168-4 · Cited by 71 · see citing works

Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)

Masson, E. A., Patmore, J., Brash, P. D., Baxter, M., Caldwell, G., GALLEN, I. W., Price, P. A., Vice, P., Walker, J. D., & Lindow, S. W. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00840.x · Cited by 66 · see citing works

Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.

Mohn, A., Strang, S., Wernicke‐Panten, K., Lang, A. M., Edge, J., & Dunger, D. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.557a · Cited by 65 · see citing works

No evidence for accumulation of insulin glargine (LANTUS®): a multiple injection study in patients with Type 1 diabetes

Heise, T., Bott, S., Rave, K., Dressler, A., Rosskamp, R., & Heinemann, L. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00723.x · Cited by 64 · see citing works

Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization

Hayward, R. A. (1997) · JAMA · doi:10.1001/jama.278.20.1663 · Cited by 61 · see citing works

Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non—insulin-dependent diabetes mellitus

Vignati, L., Anderson, J. H., & Iversen, P. W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80014-8 · Cited by 54 · see citing works

Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections

Colombel, A., Murat, A., Krempf, M., Kuchly‐Anton, B., & Charbonnel, B. H. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00077.x · Cited by 46 · see citing works

Insulin Lispro Therapy in Pregnancies Complicated by Type 1 Diabetes: Glycemic Control and Maternal and Fetal Outcomes

Garg, S. K., Frías, J. P., Anil, S., Gottlieb, P. A., MacKenzie, T. A., & Jackson, W. E. (2003) · Endocrine Practice · doi:10.4158/ep.9.3.187 · Cited by 41 · see citing works

Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin

Fineberg, N. S., Fineberg, S. E., Anderson, J. H., et al. (1996) · Diabetes · doi:10.2337/diabetes.45.12.1750 · Cited by 41 · see citing works

Insulin Aspart

Simpson, K. L., & Spencer, C. M. (1999) · Drugs · doi:10.2165/00003495-199957050-00013 · Cited by 35 · see citing works

Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

Rassam, A. G., Zeise, T. M., Burge, M. R., & Schade, D. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.133 · Cited by 34 · see citing works

Assessment of Therapy with Continuous Subcutaneous Insulin Infusion in an Academic Diabetes Clinic

Rudolph, J., & Hirsch, I. B. (2002) · Endocrine Practice · doi:10.4158/ep.8.6.401 · Cited by 31 · see citing works

Morning versus Bedtime Isophane Insulin in Type 2 (Non‐insulin dependent) Diabetes Mellitus

Seigler, D. E., Olsson, G. M., & Skyler, J. S. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01901.x · Cited by 11 · see citing works

Protein Therapeutics: A Summary and Pharmacological Classification

Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 1,913 · see citing works

Trends in peptide drug discovery

Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 2,022 · see citing works

Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline

Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277 · see citing works

Epidemiology of type 1 diabetes

Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092 · see citing works

Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894 · see citing works

Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY

Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., DeFronzo, R. A., EINHORN, D. F., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 874 · see citing works

Severe hypoglycemia in critically ill patients: risk factors and outcomes

Krinsley, J. S., & Grover, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282073.98414.4b · Cited by 671 · see citing works

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary

Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2019-0472 · Cited by 598 · see citing works

American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559 · see citing works

Diabetes mellitus and periodontal disease

Mealey, B. L., & Ocampo, G. L. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00193.x · Cited by 565 · see citing works

Rates of Complications and Mortality in Older Patients With Diabetes Mellitus: The Diabetes and Aging Study

Huang, E. S., Laiteerapong, N., Liu, J. Y., John, P. M., Moffet, H. H., & Karter, A. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12956 · Cited by 501 · see citing works

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., DeFronzo, R. A., EINHORN, D. F., Fonseca, V. A., et al. (2018) · Endocrine Practice · doi:10.4158/cs-2017-0153 · Cited by 499 · see citing works

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2017 executive summary

Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2017) · Endocrine Practice · doi:10.4158/ep161682.cs · Cited by 435 · see citing works

Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes

Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 402 · see citing works

Management of Hyperglycemia in the Hospital Setting

Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391 · see citing works

Emerging micro- and nanotechnology based synthetic approaches for insulin delivery

Mo, R., Jiang, T., Di, J., Tai, W., & Gu, Z. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60436e · Cited by 388 · see citing works

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513 · see citing works

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2019 executive summary.

Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2019) · Endocrine Practice · doi:10.4158/cs-2018-0535 · Cited by 297 · see citing works

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Joshi, G. P., Chung, F. F., Vann, M. A., Ahmad, S., Gan, T. J., Goulson, D. T., Merrill, D. G., & Twersky, R. S. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181f9c288 · Cited by 296 · see citing works

Pursuit of a perfect insulin

Zaykov, A. N., Mayer, J. P., & DiMarchi, R. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.36 · Cited by 292 · see citing works

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

Singh, S. R., Ahmad, F., Lal, A., Yu, C., Bai, Z., & Bennett, H. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081041 · Cited by 241 · see citing works

Towards peakless, reproducible and long‐acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

Heise, T., & Pieber, T. R. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00756.x · Cited by 240 · see citing works

Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates

Chou, D. H., Webber, M. J., Tang, B. C., Lin, A. B., Thapa, L. S., Deng, D., Truong, J. V., Cortinas, A. B., Langer, R., & Anderson, D. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424684112 · Cited by 237 · see citing works

Insulin structure and function

Mayer, J. P., Zhang, F. P. Y., & DiMarchi, R. D. (2007) · Biopolymers · doi:10.1002/bip.20734 · Cited by 235 · see citing works

Gender-specific care of the patient with diabetes: review and recommendations

Legato, M. J., Gelzer, A., Goland, R., Ebner, S. A., Rajan, S., Villagra, V., & Kosowski, M. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80202-0 · Cited by 225 · see citing works

Mechanisms of hypoglycemia unawareness and implications in diabetic patients

Martín-Timón, I. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.912 · Cited by 204 · see citing works

Hypoglycemia in Type 1 Diabetes Mellitus

Cryer, P. E. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.003 · Cited by 205 · see citing works

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study

Gerstein, H. C., Yale, J. ‐., Harris, S. B., Issa, M., Stewart, J. A., & Dempsey, E. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01881.x · Cited by 197 · see citing works

Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-Responsive nanoparticles vs. subcutaneous injection

Sonaje, K., Lin, K., Wey, S., Lin, C.-K., Yeh, T.-H., Nguyen, H.-N., Hsu, C., Yen, T., Juang, J., & Sung, H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.042 · Cited by 187 · see citing works

Pharmacotherapy of type 2 diabetes: An update

Upadhyay, J., Pοlyzos, S. A., Perakakis, N., Thakkar, B., Paschou, S. Α., Katsiki, N., UNDERWOOD, P. C., Park, K., Seufert, J., Kang, E. S., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.010 · Cited by 190 · see citing works

Hypoglycemia: Still The Limiting Factor in the Glycemic Management of Diabetes

Cryer, P. E. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.750 · Cited by 182 · see citing works

Insulin therapy for type 2 diabetes.

Swinnen, S. G., Hoekstra, J. B., & DeVries, J. H. (2009) · Diabetes Care · doi:10.2337/dc09-s318 · Cited by 181 · see citing works

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

Weinstein, D., Simon, M., Yehezkel, E., Laron, Z., & Werner, H. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.912 · Cited by 179 · see citing works

A novel approach using functional peptides for efficient intestinal absorption of insulin

Morishita, M., Kamei, N., Ehara, J., Isowa, K., & Takayama, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.022 · Cited by 165 · see citing works

Hydrogels in Emerging Technologies for Type 1 Diabetes

Fuchs, S., Ernst, A. U., Wang, L., Shariati, K., Wang, X., Liu, Q., & Ma, M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01062 · Cited by 160 · see citing works

Pharmacotherapy of type 2 diabetes: An update and future directions

DeMarsilis, A. J., Reddy, N., Boutari, C., Filippaios, A., Sternthal, E., Katsiki, N., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155332 · Cited by 161 · see citing works

Immunogenicity to Biologics: Mechanisms, Prediction and Reduction

Sethu, S., Govindappa, K., Alhaidari, M., Pirmohamed, M., Park, K., & Sathish, J. G. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0189-7 · Cited by 148 · see citing works

Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling

Sciacca, L., Cassarino, M. F., Genua, M., Pandini, G., Moli, R. L., Squatrito, S., & Vigneri, R. (2010) · Diabetologia · doi:10.1007/s00125-010-1760-6 · Cited by 142 · see citing works

Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients

Esposito, K., Chiodini, P., Bellastella, G., Maiorino, M. I., & Giugliano, D. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01512.x · Cited by 136 · see citing works

Clinical Application of Emerging Sensor Technologies in Diabetes Management: Consensus Guidelines for Continuous Glucose Monitoring (CGM)

Hirsch, I. B., Armstrong, D. U., Bergenstal, R. M., Buckingham, B. A., Childs, B. P., Clarke, W. L., Peters, A. L., & Wolpert, H. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0016 · Cited by 136 · see citing works

Insulin Units and Conversion Factors: A Story of Truth, Boots, and Faster Half-Truths

Knopp, J. L., Holder-Pearson, L. R., & Chase, J. G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818805074 · Cited by 134 · see citing works

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs

Lankisch, M., Ferlinz, K., Leahy, J. L., Scherbaum, W. A., & Orals Plus Apidra and LANTUS (OPAL) study group (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00967.x · Cited by 133 · see citing works

The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy

McElduff, A., Cheung, N. W., McIntyre, D. H., Lagstrom, J., Walters, B. N. J., Oats, J. J. N., Wein, P., Ross, G. P., & Simmons, D. S. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb07087.x · Cited by 131 · see citing works

Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease

Cleveland, K. H., & Schnellmann, R. G. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000560 · Cited by 130 · see citing works

Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes

Giugliano, D., Maiorino, M. I., Bellastella, G., Chiodini, P., Ceriello, A., & Esposito, K. (2011) · Diabetes Care · doi:10.2337/dc10-1710 · Cited by 127 · see citing works

New Drugs for Type 2 Diabetes Mellitus

Krentz, A. J., Patel, M., & Bailey, C. J. (2008) · Drugs · doi:10.2165/00003495-200868150-00005 · Cited by 121 · see citing works

Diabetes mellitus and other disorders of metabolism

(2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-2993-6.00024-9 · Cited by 122 · see citing works

Exercise and Glycemic Control in Diabetes: Benefits, Challenges, and Adjustments to Pharmacotherapy

Gulve, E. A. (2008) · Physical Therapy · doi:10.2522/ptj.20080114 · Cited by 120 · see citing works

Rapid Pharmacokinetics of Intradermal Insulin Administered Using Microneedles in Type 1 Diabetes Subjects

Gupta, J., Felner, E. I., & Prausnitz, M. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0204 · Cited by 118 · see citing works

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Ólafsdóttir, A. F., Polonsky, W. H., Bolinder, J., Hirsch, I. B., Dahlqvist, S., Wedel, H., Nyström, T., Wijkman, M. O., Schwarcz, E., Hellman, J., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0363 · Cited by 115 · see citing works

Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, and Applications

Lombardi, L., Genio, V. D., Alberício, F., & Williams, D. R. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00989 · Cited by 126 · see citing works

Insulin therapy in renal disease

Iglesias, P., & Díez, J. J. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00802.x · Cited by 110 · see citing works

Immune therapy in type 1 diabetes mellitus

Lernmark, Å., & Larsson, H. E. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.237 · Cited by 109 · see citing works

Lipodystrophy Reactions to Insulin

Radermecker, R. P., rard, G. R. E. P., & Scheen, A. J. (2007) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200708010-00003 · Cited by 107 · see citing works

What's fueling the biotech engine?

Aggarwal, S. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1097 · Cited by 105 · see citing works

MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview

Diamanti‐Kandarakis, E., Dattilo, M., Μacut, D., Duntas, L. H., Gonos, E. S., Goulis, D. G., Kanaka‐Gantenbein, C., Καπετάνου, Μ., Koukkou, E. G., Lambrinoudaki, I. V., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1061 · Cited by 103 · see citing works

Smart approaches to glucose-responsive drug delivery

Webber, M. J., & Anderson, D. G. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1055749 · Cited by 103 · see citing works

Basal insulin analogues in the management of diabetes mellitus: what progress have we made?

Owens, D. R., Matfin, G., & Monnier, L. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2469 · Cited by 102 · see citing works

Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues

Radermecker, R. P., & Scheen, A. J. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.714 · Cited by 100 · see citing works

Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus

Breton, M. D., Patek, S. D., Lv, D., Schertz, E. M., Robic, J., Pinnata, J., Kollar, L. L., Barnett, C. L., WAKEMAN, C. A., Oliveri, M. C., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0079 · Cited by 98 · see citing works

15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026

Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 114 · see citing works

Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer

Morden, N. E., Liu, S. K., Smith, J., MacKenzie, T. A., Skinner, J., & Korc, M. (2011) · Diabetes Care · doi:10.2337/dc11-0699 · Cited by 94 · see citing works

Refining basal insulin therapy: what have we learned in the age of analogues?

DeVries, J. H., Nattrass, M., & Pieber, T. R. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.762 · Cited by 94 · see citing works

Management of Gestational Diabetes: Pharmacologic Treatment Options and Glycemic Control

Langer, O. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.09.007 · Cited by 91 · see citing works

Diabetes in pregnancy: health risks and management

Ali, S. N., & Dornhorst, A. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.109157 · Cited by 88 · see citing works

Insulin Use in Elderly Adults: Risk of Hypoglycemia and Strategies for Care

Ligthelm, R. J., Kaiser, M., Vora, J. P., & Yale, J. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04055.x · Cited by 89 · see citing works

Proinsulin and the Genetics of Diabetes Mellitus

Weiss, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.009936 · Cited by 89 · see citing works

New advances in type 1 diabetes

Subramanian, S., Khan, F. N., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 101 · see citing works

Insulin Stacking Versus Therapeutic Accumulation: Understanding the Differences

Heise, T., & Meneghini, L. F. (2014) · Endocrine Practice · doi:10.4158/ep13090.ra · Cited by 87 · see citing works

The role of polysaccharides from natural resources to design oral insulin micro- and nanoparticles intended for the treatment of Diabetes mellitus: A review

Meneguin, A. B., Silvestre, A. L. P., Spósito, L., de Souza, M. P. C., Sábio, R. M., Araújo, V. H. S., Cury, B. S. F., & Chorilli, M. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117504 · Cited by 87 · see citing works

Basal Insulin: Physiology, Pharmacology, and Clinical Implications

Niswender, K. D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2300 · Cited by 88 · see citing works

The Contribution of Malglycemia to Mortality among Allogeneic Hematopoietic Cell Transplant Recipients

Hammer, M. J., Casper, C., Gooley, T. A., O’Donnell, P. V., Boeckh, M., & Hirsch, I. B. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.12.488 · Cited by 85 · see citing works

A Review of Types 1 and 2 Diabetes Mellitus and Their Treatment with Insulin

Salsali, A., & Nathan, M. (2006) · American Journal of Therapeutics · doi:10.1097/00045391-200607000-00012 · Cited by 85 · see citing works

Insulin Therapy in Children and Adolescents with Type 1 Diabetes

Malik, F. S., & Taplin, C. E. (2014) · Pediatric Drugs · doi:10.1007/s40272-014-0064-6 · Cited by 84 · see citing works

Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison

Ilag, L. L., Kerr, L., Malone, J. K., & Tan, M. H. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.003 · Cited by 84 · see citing works

Canine Diabetes Mellitus

Nelson, R. W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4456-5.00006-7 · Cited by 86 · see citing works

Insulin Glulisine Complementing Basal Insulins: A Review of Structure and Activity

Becker, R. H. A. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0035 · Cited by 84 · see citing works

Toward a Fully Automated Artificial Pancreas System Using a Bioinspired Reinforcement Learning Design: In Silico Validation

Lee, S., Kim, J., Park, S. W., Jin, S., & Park, S. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3002022 · Cited by 86 · see citing works

Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities

Monnier, L., & Colette, C. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70241-0 · Cited by 82 · see citing works

Intradermal Microneedle Delivery of Insulin Lispro Achieves Faster Insulin Absorption and Insulin Action than Subcutaneous Injection

Pettis, R. J., Ginsberg, B. H., Hirsch, L. J., Sutter, D. E., Keith, S., McVey, E., Harvey, N. G., Hompesch, M., Nosek, L., Kapitza, C., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0184 · Cited by 82 · see citing works

Why is there no generic insulin? Historical origins of a modern problem

Greene, J. A., & Riggs, K. R. (2015) · New England Journal of Medicine · doi:10.1056/nejmms1411398 · Cited by 81 · see citing works

Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist

Hirsch, I. B. (2009) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2008-2625 · Cited by 93 · see citing works

The past, present, and future of basal insulins

Pettus, J., Cavaiola, T. S., Tamborlane, W. V., & Edelman, S. V. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2763 · Cited by 80 · see citing works

Targeting postprandial hyperglycemia

Rendell, M., & Jovanovič, L. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.012 · Cited by 80 · see citing works

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes

Laffel, L. M., Aleppo, G., Buckingham, B. A., Forlenza, G. P., Rasbach, L. E., Tsalikian, E., Weinzimer, S. A., & Harris, D. R. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00389 · Cited by 79 · see citing works

Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin

Rave, K., Potocka, E., Boss, A., Marino, M. T., Costello, D. G., & Chen, R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01039.x · Cited by 79 · see citing works

Management of diabetes mellitus: is the pump mightier than the pen?

Pickup, J. C. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.28 · Cited by 77 · see citing works

Intrinsic Fibrillation of Fast-Acting Insulin Analogs

Woods, R., Alarcón, J., McVey, E., & Pettis, R. J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600209 · Cited by 67 · see citing works

Oral delivery of diabetes peptides — Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context

Reddy, L. H., Urmann, M., Besenius, M., Ulrich, W., Haack, T., Brun, P., Alié, J., Illel, B., Hortala, L., Vogel, R., et al. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.011 · Cited by 71 · see citing works

Modeling Day-to-Day Variability of Glucose–Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery

Ruan, Y., Wilinska, M. E., Thabit, H., & Hovorka, R. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2590498 · Cited by 71 · see citing works

Technosphere ® Insulin Technology

Richardson, P. C., & Boss, A. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0212 · Cited by 70 · see citing works

Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases

Yeo, X. Y., Cunliffe, G., Ho, R., Lee, S. S., & Jung, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020343 · Cited by 65 · see citing works

Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review

Rys, P., Pankiewicz, O., Lach, K., Kwaskowski, A., Skrzekowska-Baran, I., & Malecki, M. T. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.12.003 · Cited by 64 · see citing works

Clinical utility of insulin and insulin analogs

Şanlioğlu, A. D., Altunbaş, H., Balcı, M. K., Griffith, T. S., & Şanlıoğlu, S. (2013) · Islets · doi:10.4161/isl.24590 · Cited by 64 · see citing works

The use of insulin analogues in pregnancy

Lambert, K., & Holt, R. I. G. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12098 · Cited by 64 · see citing works

Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction

Chen, W., Yung, B. C., Qian, Z., & Chen, X. S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.016 · Cited by 62 · see citing works

Site-Specific Insulin-Trehalose Glycopolymer Conjugate by Grafting from Strategy Improves Bioactivity

Mansfield, K. M., & Maynard, H. D. (2018) · ACS Macro Letters · doi:10.1021/acsmacrolett.7b00974 · Cited by 63 · see citing works

Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom?

Monnier, L., Colette, C., Boegner, C., Pham, T. C., Lapinski, H., & Boniface, H. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2006.11.007 · Cited by 61 · see citing works

Insulin's 85th anniversary—An enduring medical miracle

Heller, S. R., Kozlovski, P., & Kurtzhals, P. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.04.001 · Cited by 63 · see citing works

Controlled release of biologics for the treatment of type 2 diabetes

Gilroy, C. A., Luginbuhl, K. M., & Chilkoti, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.002 · Cited by 62 · see citing works

Hypoglycemia with New Generation Basal Analog Insulins: A Descriptive Critical Review

Thrasher, M. A. J. R. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000576

Insulin analogues in the management of diabetes

Vázquez‐Carrera, M., & Silvestre, J. S. (2004) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2004.26.6.831318 · Cited by 37 · see citing works

The role of insulin analogues in the current treatment of diabetes mellitus

Mitrović, M., Pantelinac, P., Radosavljevic, J., Bajkin, I. A., & Todorovic-Djilas, L. (2006) · Medicinski pregled · doi:10.2298/mpns0612539m · Cited by 3 · see citing works

Role of New Insulin Analogs in the Management of Diabetes. A Clinical Review

Aziz, K. M. A. (2023) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000269

New Insulin Analogues and Routes of Delivery

Roach, P. J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847090-00003 · Cited by 31 · see citing works